MA24273A1 - (4-arylthiazol-2yl) sulfonamides et leur utilisation - Google Patents

(4-arylthiazol-2yl) sulfonamides et leur utilisation

Info

Publication number
MA24273A1
MA24273A1 MA24722A MA24722A MA24273A1 MA 24273 A1 MA24273 A1 MA 24273A1 MA 24722 A MA24722 A MA 24722A MA 24722 A MA24722 A MA 24722A MA 24273 A1 MA24273 A1 MA 24273A1
Authority
MA
Morocco
Prior art keywords
arylthiazol
sulfonamides
Prior art date
Application number
MA24722A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA24273A1 publication Critical patent/MA24273A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA24722A 1996-07-19 1997-07-17 (4-arylthiazol-2yl) sulfonamides et leur utilisation MA24273A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96111661 1996-07-19

Publications (1)

Publication Number Publication Date
MA24273A1 true MA24273A1 (fr) 1998-04-01

Family

ID=8223010

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24722A MA24273A1 (fr) 1996-07-19 1997-07-17 (4-arylthiazol-2yl) sulfonamides et leur utilisation

Country Status (23)

Country Link
US (2) US5877193A (fr)
EP (1) EP0819681A3 (fr)
JP (1) JP2991679B2 (fr)
KR (1) KR100247672B1 (fr)
CN (1) CN1176101A (fr)
AU (1) AU725496B2 (fr)
BR (1) BR9704023A (fr)
CA (1) CA2210613A1 (fr)
CO (1) CO4900053A1 (fr)
CZ (1) CZ227397A3 (fr)
HR (1) HRP970393A2 (fr)
HU (1) HUP9701193A3 (fr)
IL (1) IL121298A (fr)
MA (1) MA24273A1 (fr)
MX (1) MX9705385A (fr)
NO (1) NO973338L (fr)
NZ (1) NZ328331A (fr)
PE (1) PE91298A1 (fr)
PL (1) PL321203A1 (fr)
SG (1) SG91796A1 (fr)
TR (1) TR199700653A2 (fr)
YU (1) YU30297A (fr)
ZA (1) ZA976222B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725138D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Thiophenesulfonamide compounds
GB9725141D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Benzenesulfonamide compounds
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent
SE0001899D0 (sv) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
CA2436526C (fr) * 2000-12-13 2010-10-19 Wyeth Inhibiteurs sulfonamides heterocycliques de la production de beta-amyloide
RS44304A (en) 2001-11-22 2007-06-04 Biovitrum Ab., Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
FR2849599B1 (fr) * 2003-01-07 2006-12-29 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete
FR2849598B1 (fr) * 2003-01-07 2006-09-22 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
WO2005054216A1 (fr) * 2003-12-01 2005-06-16 Reverse Proteomics Research Institute Co., Ltd. Nouvel agent anticancereux 'sulcoxine'
EP2054056A4 (fr) * 2006-08-16 2010-08-25 J David Gladstone Inst A Testa Petits inhibiteurs moleculaires de la kynurenine-3- monooxygenase
US7994338B2 (en) 2006-08-16 2011-08-09 The J. David Gladstone Institutes Small molecule inhibitors of kynurenine-3-monooxygenase
CA2712071A1 (fr) * 2008-01-15 2009-10-08 Siga Technologies, Inc. Medicaments antiviraux pour le traitement d'une infection par un arenavirus
WO2009124086A2 (fr) * 2008-04-04 2009-10-08 Siga Technologies, Inc. Médicament antibactérien pour le traitement d’infections à staphylococcus aureus et d’autres bactéries gram positif
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
CN101602687A (zh) * 2008-06-13 2009-12-16 上海特化医药科技有限公司 6-硝基苯乙酮类化合物、其制备方法及用途
ES2629194T3 (es) * 2011-08-30 2017-08-07 Chdi Foundation, Inc. Inhibidores de kinurenina-3-monoxigenasa, composiciones farmacéuticas y métodos de utilización del mismo
CN102633687B (zh) * 2012-04-05 2016-06-08 天津瑞岭化工有限公司 一种对位取代烷基苯磺酰氯的制备方法和工艺
CN102633695A (zh) * 2012-04-05 2012-08-15 天津理工大学 一种4-异丙基苯磺酰氯的制备方法和工艺
CN102633696A (zh) * 2012-04-05 2012-08-15 天津理工大学 一种两步合成制备对位取代烷基苯磺酰氯的方法和工艺
CN102627589A (zh) * 2012-04-05 2012-08-08 天津理工大学 一种两步合成制备4-异丙基苯磺酰氯的方法和工艺
EP3345596B1 (fr) * 2012-09-21 2021-01-20 Rhode Island Hospital Inhibiteurs de bêta-hydrolase pour le traitement du cancer
RU2769827C2 (ru) 2016-05-20 2022-04-06 Ксенон Фармасьютикалз Инк. Соединения бензолсульфонамида и их применение в качестве терапевтических средств
US20180162868A1 (en) 2016-12-09 2018-06-14 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
MX2020013317A (es) 2018-06-13 2021-04-13 Xenon Pharmaceuticals Inc Compuestos de bencenosulfonamida y su uso como agentes terapeuticos.
KR20210054510A (ko) 2018-08-31 2021-05-13 제논 파마슈티칼스 인크. 헤테로아릴-치환된 술폰아미드 화합물 및 치료제로서의 그의 용도
WO2020047312A1 (fr) 2018-08-31 2020-03-05 Xenon Pharmaceuticals Inc. Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
CN114516807B (zh) * 2022-02-24 2023-11-17 南京大学 一种含硝基多取代芳香二胺单体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
NZ247440A (en) * 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
WO1996016650A1 (fr) * 1994-11-29 1996-06-06 Hisamitsu Pharmaceutical Co., Inc. Antibacterien et bactericide comprenant un derive de 2-aminothiazole et sels de ce derive
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives

Also Published As

Publication number Publication date
IL121298A (en) 2001-03-19
CZ227397A3 (cs) 1998-02-18
EP0819681A3 (fr) 1998-02-04
BR9704023A (pt) 1998-11-17
NZ328331A (en) 1999-05-28
US5958910A (en) 1999-09-28
KR100247672B1 (ko) 2000-04-01
YU30297A (sh) 2000-10-30
IL121298A0 (en) 1998-01-04
NO973338L (no) 1998-01-20
SG91796A1 (en) 2002-10-15
HUP9701193A3 (en) 2000-08-28
US5877193A (en) 1999-03-02
AU725496B2 (en) 2000-10-12
HU9701193D0 (en) 1997-09-29
KR980008228A (ko) 1998-04-30
CN1176101A (zh) 1998-03-18
MX9705385A (es) 1998-04-30
JP2991679B2 (ja) 1999-12-20
TR199700653A2 (xx) 1998-02-21
EP0819681A2 (fr) 1998-01-21
CO4900053A1 (es) 2000-03-27
PE91298A1 (es) 1998-12-31
ZA976222B (en) 1998-01-19
CA2210613A1 (fr) 1998-01-19
NO973338D0 (no) 1997-07-18
JPH1067761A (ja) 1998-03-10
HRP970393A2 (en) 1998-04-30
PL321203A1 (en) 1998-02-02
HUP9701193A2 (hu) 1999-02-01
AU2875297A (en) 1998-01-29

Similar Documents

Publication Publication Date Title
MA24273A1 (fr) (4-arylthiazol-2yl) sulfonamides et leur utilisation
MA24237A1 (fr) Sulfonamides et leur utilisation.
NO984316D0 (no) Skjµreverkt°y
ID15921A (id) Peralatan pengeringan
DE69703584D1 (de) Kaskadierter anschluss von kommunizierenden geräte
NO983462D0 (no) Isoleringsverkt°y
ID17873A (id) Penghambat trombin baru
NO990552L (no) Innrettingsverkt°y
DE69714146D1 (de) Polyether modifizierte Fluoralkylsiloxane
BR9708248A (pt) Benzotiofenos formulações contendo os mesmos e metódos
BR9707657A (pt) Benzotiofenos formulações contendo os mesmos e métodos
FR2757398B1 (fr) Formulation de bambuterol et son utilisation
FR2722198B1 (fr) 1derives de silylmethyl-anilines, le2fabrication, et leur utilisation co
ID16791A (id) Peralatan pengering
DE29607080U1 (de) Fingerabdruckschalter
DE69736101D1 (de) Y/C-Zweizeilen-Trennvorrichtung
DE69714188D1 (de) Y/C-Trennstufe
DE29610847U1 (de) Zauberkarte
KR980000320U (ko) 뺏지 부착용 핀
DE29612712U1 (de) Spielekoffer
DE29613171U1 (de) Puzzle
DE29609091U1 (de) Funktions-Karte
DE29620201U1 (de) Kombinatorisches Geduldsspiel
DE29620301U1 (de) Frisörarbeitsgerätschaft
KR980000319U (ko) 뺏지 부착용 핀